TransMolecular Inc.
This article was originally published in Start Up
Executive Summary
TransMolecular Inc. is exploring ion channels as pharmaceutical targets in three areas: the deadly brain cancers called gliomas; chronic pain; edema suffered by trauma and stroke victims.